News
Stanford's George Tidmarsh has authored 143 scientific papers and patents, as well as played a central role in developing seven FDA-approved drugs.
George Francis Tidmarsh, MD, PhD, founding co-director of Stanford’s Master of Translational Research and Applied Medicine program, has been appointed as the new director of the Center for Drug ...
The FDA on Tuesday rejected a skin therapy from Replimune Group, suggesting a hardened stance on drug approvals under new agency officials ...
The FDA in 2022 had banned Juul’s four varieties of tobacco and menthol-flavored pods and the e-cigarette device after it concluded that the company failed to show that sale of these products… ...
The FDA cracked down on two plants in India and one in Korea in separate recently released reports, citing issues ranging from mold to skirted testing procedures.
FDA names former pharmaceutical company executive to oversee US drug program FDA's drug center hasn’t had a permanent director since January, when Dr. Patrizia Cavazzoni stepped down days before ...
Members of an FDA expert panel discussed reassessing boxed warnings for menopausal HT and how to better educate patients and health care professionals.
The FDA has approved another natural dye for use in foods, continuing its war on artificial, petroleum-based food colorings. The new color is gardinea ...
The FDA will hold a panel discussion Thursday on hormone therapy for menopausal women.
FDA Inspectors Again Find Dangerous Breakdowns at an Indian Factory Supplying Medications to U.S. Consumers The latest inspection comes 2 1/2 years after the agency allowed Sun Pharma to keep ...
The FDA suggested that Columvi's phase 3 data do not provide enough evidence to support the proposed indication in a U.S. population, Roche said.
Officials with the Food and Drug Administration have approved the continued sales of tobacco-flavored e-cigarettes and refill cartridges by Juul Labs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results